Explore more publications!
Reunion Health News
Got News to Share?

Press Releases

Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
Feb. 13, 2026

Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom

Indeterminate GlobeNewswire, Inc.
Public Health Action Network Is A Partnering Organization for the 'Healthy Indoor Air' Event at the UN General Assembly
Sep. 22, 2025

Public Health Action Network Is A Partnering Organization for the 'Healthy Indoor Air' Event at the UN General Assembly

Neutral EIN Presswire
WHO cautions of increase of chikungunya disease
Jul. 29, 2025

WHO cautions of increase of chikungunya disease

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

TGR Foundation Celebrates 20 Years of Impact Through Education at TGR Learning Lab in Anaheim
Feb. 10, 2026

TGR Foundation Celebrates 20 Years of Impact Through Education at TGR Learning Lab in Anaheim

Indeterminate GlobeNewswire, Inc.
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
May. 7, 2025

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

Indeterminate GlobeNewswire, Inc.
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Apr. 26, 2025

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities

Indeterminate GlobeNewswire, Inc.
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
Mar. 24, 2025

Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion

Indeterminate GlobeNewswire, Inc.
Hypersante Introduces the 2026 Longevity and Biohacking Summit in Paris
Dec. 11, 2025

Hypersante Introduces the 2026 Longevity and Biohacking Summit in Paris

Indeterminate GlobeNewswire, Inc.
Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates
Nov. 20, 2025

Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire, Inc.
GBSA connects Pangyo’s innovative companies with global media outlets through the 2025 Pangyo Global Media Meet-Up
Nov. 10, 2025

GBSA connects Pangyo’s innovative companies with global media outlets through the 2025 Pangyo Global Media Meet-Up

Neutral EIN Presswire
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Aug. 12, 2025

Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire, Inc.
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance - Publication of Circular for Combined Annual General Meeting of September 30, 2025
Sep. 9, 2025

OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance - Publication of Circular for Combined Annual General Meeting of September 30, 2025

Indeterminate GlobeNewswire, Inc.
WHO cautions against increase of chikungunya illness
Jul. 28, 2025

WHO cautions against increase of chikungunya illness

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

WHO Cautions Chikungunya Spread Threatens Billions
Jul. 22, 2025

WHO Cautions Chikungunya Spread Threatens Billions

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Aug. 25, 2025

Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.

Indeterminate GlobeNewswire, Inc.
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Aug. 7, 2025

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information

Indeterminate GlobeNewswire, Inc.
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
May. 12, 2025

Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States

Indeterminate GlobeNewswire, Inc.
Combined General Meeting of June 11, 2025
May. 15, 2025

Combined General Meeting of June 11, 2025

Indeterminate GlobeNewswire, Inc.
Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA
Mar. 31, 2025

Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA

Indeterminate GlobeNewswire, Inc.
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
Apr. 18, 2025

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions